# The β-adrenergic receptor-SGK1 signaling pathway in brown adipocytes protects GOT1 from proteasomal degradation

**Authors:** Chul-Hong Park, Minsung Park, J. Jason Collier, Ji Suk Chang

PMC · DOI: 10.3389/fcell.2025.1637770 · Frontiers in Cell and Developmental Biology · 2025-07-16

## TL;DR

A new pathway involving β-adrenergic receptor and SGK1 protects GOT1 protein from breakdown in brown fat cells during cold exposure.

## Contribution

Discovery of βAR-SGK1 signaling as a novel mechanism for GOT1 protein stabilization in brown adipocytes.

## Key findings

- SGK1 activation downstream of βAR signaling prevents GOT1 ubiquitination and proteasomal degradation.
- Pharmacological or genetic inhibition of SGK1 reduces GOT1 protein levels without affecting mRNA.
- βAR-SGK1 signaling supports metabolic adaptation in brown adipocytes during cold exposure.

## Abstract

The malate-aspartate shuttle (MAS) is a key biochemical system that facilitates the transfer of reducing equivalents from the cytosol into mitochondria. It consists of two pairs of cytosolic and mitochondrial enzymes: glutamic-oxaloacetic transaminases (cGOT1, mGOT2) and malate dehydrogenases (cMDH1, mMDH2). We recently reported that cytosolic GOT1 is selectively elevated in brown adipocytes during cold exposure, while the expression of other MAS enzymes remains unchanged. Mechanistically, cold-induced activation of the β-adrenergic receptor (βAR)-cAMP-PKA signaling pathway promotes Got1 transcription through the transcriptional coactivators PGC-1α and NT-PGC-1α. The resulting increase in GOT1 levels activates the MAS, thereby supporting mitochondrial respiration through enhanced fatty acid oxidation. In the present study, we identify the βAR-SGK1 (Serum- and Glucocorticoid-inducible Kinase 1) signaling axis as a novel regulatory mechanism that maintains GOT1 protein stability. SGK1 is activated downstream of βAR signaling in brown adipocytes during cold exposure. We show that expression of SGK1S422D, a constitutively active form of SGK1, protects GOT1 from ubiquitination by the E3 ubiquitin ligase RNF34 and subsequent degradation by the proteasome. Conversely, both pharmacological and genetic inhibition of SGK1 during βAR stimulation leads to a reduction in GOT1 protein levels without altering its mRNA expression. Together, these findings uncover a previously unrecognized role for the βAR-SGK1 signaling pathway in maintaining GOT1 protein stability in brown adipocytes, highlighting a multilayered signaling network that orchestrates metabolic adaptation during cold-induced activation.

## Linked entities

- **Genes:** GOT1 (glutamic-oxaloacetic transaminase 1) [NCBI Gene 2805], SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446], RNF34 (ring finger protein 34) [NCBI Gene 80196], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], ADRB2 (adrenoceptor beta 2) [NCBI Gene 154]
- **Proteins:** GOT1 (glutamic-oxaloacetic transaminase 1), SGK1 (serum/glucocorticoid regulated kinase 1), RNF34 (ring finger protein 34), PPARGC1A (PPARG coactivator 1 alpha)

## Full-text entities

- **Genes:** Sgk2 (serum/glucocorticoid regulated kinase 2) [NCBI Gene 27219] {aka Sgkl}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NDRG1 (N-myc downstream regulated 1) [NCBI Gene 10397] {aka CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL}, UBE2H (ubiquitin conjugating enzyme E2 H) [NCBI Gene 7328] {aka E2-20K, GID3, UBC8, UBCH, UBCH2}, MDH1 (malate dehydrogenase 1) [NCBI Gene 4190] {aka DEE88, EIEE88, HEL-S-32, KAR, MDH-s, MDHA}, SGK2 (serum/glucocorticoid regulated kinase 2) [NCBI Gene 10110] {aka H-SGK2, dJ138B7.2}, NEDD4L (NEDD4 like E3 ubiquitin protein ligase) [NCBI Gene 23327] {aka NEDD4-2, NEDD4.2, PVNH7, RSP5, hNEDD4-2}, GOT2 (glutamic-oxaloacetic transaminase 2) [NCBI Gene 2806] {aka DEE82, KAT4, KATIV, KYAT4, mitAAT}, Rnf34 (ring finger protein 34) [NCBI Gene 80751] {aka RIFF}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, Sgk1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 20393] {aka Sgk}, UCP1 (uncoupling protein 1) [NCBI Gene 7350] {aka SLC25A7, UCP}, SGK3 (serum/glucocorticoid regulated kinase family member 3) [NCBI Gene 23678] {aka CISK, SGK2, SGKL}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, Ndrg1 (N-myc downstream regulated gene 1) [NCBI Gene 17988] {aka CAP43, CMT4D, DRG1, HMSNL, NMSL, Ndr1}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, SLC25A11 (solute carrier family 25 member 11) [NCBI Gene 8402] {aka OGC, PGL6, PPGL6, SLC20A4}, Rapgef3 (Rap guanine nucleotide exchange factor (GEF) 3) [NCBI Gene 223864] {aka 2310016P22Rik, 9330170P05Rik, Epac, Epac1}, GOT1 (glutamic-oxaloacetic transaminase 1) [NCBI Gene 2805] {aka AST, AST1, ASTQTL1, GIG18, SGOT, cAspAT}, SLC25A19 (solute carrier family 25 member 19) [NCBI Gene 60386] {aka DNC, MCPHA, MTPPT, MUP1, THMD3, THMD4}, MDH2 (malate dehydrogenase 2) [NCBI Gene 4191] {aka DEE51, EIEE51, M-MDH, MDH, MGC:3559, MOR1}, Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, CAMP (cathelicidin antimicrobial peptide) [NCBI Gene 820] {aka CAP-18, CAP18, CRAMP, FALL-39, FALL39, HSD26}, RNF34 (ring finger protein 34) [NCBI Gene 80196] {aka CARP-1, CARP1, RFI, RIF, RIFF, hRFI}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Got1 (glutamic-oxaloacetic transaminase 1, soluble) [NCBI Gene 14718] {aka Got-1, cAspAT, cCAT}, DNAH8 (dynein axonemal heavy chain 8) [NCBI Gene 1769] {aka ATPase, SPGF46, hdhc9}, PDK1 (pyruvate dehydrogenase kinase 1) [NCBI Gene 5163], Crtc2 (CREB regulated transcription coactivator 2) [NCBI Gene 74343] {aka 4632407F12Rik, Torc2}, Fabp4 (fatty acid binding protein 4, adipocyte) [NCBI Gene 11770] {aka 422/aP2, AFABP, ALBP, ALBP/Ap2, Ap2, Lbpl}, Bfar (bifunctional apoptosis regulator) [NCBI Gene 67118] {aka 3010001A07Rik, 3110001I22Rik, Bar, Rnf47}, MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446] {aka SGK}, ADRB2 (adrenoceptor beta 2) [NCBI Gene 154] {aka ADRB2R, ADRBR, ARB2, B2AR, BAR, BETA2AR}, MIR95 (microRNA 95) [NCBI Gene 407052] {aka MIRN95, hsa-mir-95, miR-95}
- **Diseases:** obesity (MESH:D009765), pancreatic cancer (MESH:D010190), hypoxia (MESH:D000860), pulmonary arterial hypertension (MESH:D000081029), metabolic disorders (MESH:D008659)
- **Chemicals:** T3 (MESH:D014284), SYBR Green (MESH:C098022), sodium (MESH:D012964), GSK650394 (MESH:C532254), aspartate (MESH:D001224), malate (MESH:C030298), agarose (MESH:D012685), MG132 (MESH:C072553), AA (MESH:D000968), indomethacin (MESH:D007213), norepinephrine (MESH:D009638), GSK690693 (MESH:C528328), IBMX (MESH:D015056), dexamethasone (MESH:D003907), ISO (MESH:D007545), HEPES (MESH:D006531), Oxygen (MESH:D010100), CHX (MESH:D003513), salt (MESH:D012492), fatty acid (MESH:D005227), Penicillin (MESH:D010406), NaCl (MESH:D012965), ATP (MESH:D000255), NP-40 (MESH:C010615), KU0063794 (MESH:C541932), NADH (MESH:D009243), Streptomycin (MESH:D013307), Oligo (MESH:D009840), FCCP (MESH:D002259), carbon dioxide (MESH:D002245), BKO (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S356D, S422D, Ser356, Ser422, serine/threonine
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307365/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12307365/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307365/full.md

---
Source: https://tomesphere.com/paper/PMC12307365